Life Sciences 2025

UK Law and Practice Contributed by: Jackie Mulryne, Ewan Townsend, Adela Williams and Libby Amos-Stone, Arnold & Porter

Adela Williams is a partner at Arnold & Porter, specialising in life sciences regulatory advice and litigation. She provides a broad range of advice in relation to medicines, medical devices,

Libby Amos-Stone acts for life sciences companies in product liability and public law litigation. She also advises clients on the pharmaceutical, medical device, food, cosmetic and cannabis

cosmetics and foods and has extensive experience in pricing and reimbursement matters, assisting clients to navigate the Voluntary and Statutory Schemes on the pricing of branded medicines and providing support and representation in the context of health technology appraisals by NICE and similar bodies. Adela also acts for clients in litigation arising from regulatory decisions in UK and European courts, and represents pharmaceutical and medical device clients in product liability litigation.

regulatory frameworks, and assists companies on strategic issues arising during the life cycle of pharmaceutical products. Libby advises companies on the boundaries of the ABPI and EFPIA codes of practice, and UK and EU legislation regarding the promotion of medicinal products, including use of social media.

Arnold & Porter Tower 42 25 Old Broad Street London EC2N 1HQ UK

Tel: +44 20 7786 6100 Fax: +44 20 7786 6299 Email: jacqueline.mulryne@arnoldporter.com Web: www.arnoldporter.com

359 CHAMBERS.COM

Powered by